ECO Animal Health Group plc (LON:EAH) Insider Buys £19,999.10 in Stock

ECO Animal Health Group plc (LON:EAH) insider David Hallas bought 18,181 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were bought at an average cost of GBX 110 ($1.45) per share, for a total transaction of £19,999.10 ($26,297.30).

ECO Animal Health Group Stock Down 2.2 %

EAH stock opened at GBX 112 ($1.47) on Thursday. ECO Animal Health Group plc has a twelve month low of GBX 82.67 ($1.09) and a twelve month high of GBX 135 ($1.78). The company has a quick ratio of 2.14, a current ratio of 2.96 and a debt-to-equity ratio of 4.31. The company has a market cap of £75.87 million, a PE ratio of 5,600.00 and a beta of -0.05. The business’s 50-day simple moving average is GBX 111.84 and its 200 day simple moving average is GBX 107.76.

Analyst Upgrades and Downgrades

Separately, Shore Capital restated a “buy” rating on shares of ECO Animal Health Group in a research report on Tuesday, August 27th.

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.